| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.73 | 0.003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |